| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Daniel Cuevas-Ramos, Shlomo Melme. Acromegaly Type 1: A Representative Patient. JCEM case reports. vol 2. issue 4. 2024-04-18. PMID:38633358. |
biochemical evaluation, including insulin-like growth factor type 1 (igf-1) measurement and oral glucose loading with growth hormone (gh) measurement confirmed excess gh production and a diagnosis of acromegaly. |
2024-04-18 |
2024-04-20 |
Not clear |
| Busra Firlatan, Ugur Nadir Karakulak, Vedat Hekimsoy, Burcin Gonul Iremli, Incilay Lay, Deniz Yuce, Selcuk Dagdelen, Giray Kabakci, Tomris Erba. Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly. Hormones (Athens, Greece). 2024-04-17. PMID:38632216. |
in patients with acromegaly, the long-term presence of elevated gh and igf-1 levels is associated with an unfavorable cardiovascular risk profile. |
2024-04-17 |
2024-04-20 |
Not clear |
| Federica Guaraldi, Francesca Ambrosi, Costantino Ricci, Luisa Di Sciascio, Sofia Asiol. Histopathology of growth hormone-secreting pituitary tumors: State of the art and new perspectives. Best practice & research. Clinical endocrinology & metabolism. 2024-04-13. PMID:38614953. |
somatotroph (gh) adenomas/pitnets typically arise from adenohypophysis and are biochemically active, leading to acromegaly and gigantism. |
2024-04-13 |
2024-04-16 |
Not clear |
| Kohei Oguni, Koichiro Yamamoto, Yasuhiro Nakano, Yoshiaki Soejima, Atsuhito Suyama, Ryosuke Takase, Miho Yasuda, Kou Hasegawa, Fumio Otsuk. Trends of correlations between serum levels of growth hormone and insulin-like growth factor-I in general practice. Frontiers in endocrinology. vol 15. 2024-04-10. PMID:38596224. |
of 642 patients, 33 patients were diagnosed with acromegaly, 21 were diagnosed with gh deficiency (ghd), and 588 were diagnosed with non-gh-related diseases (ngrd). |
2024-04-10 |
2024-04-12 |
Not clear |
| Kohei Oguni, Koichiro Yamamoto, Yasuhiro Nakano, Yoshiaki Soejima, Atsuhito Suyama, Ryosuke Takase, Miho Yasuda, Kou Hasegawa, Fumio Otsuk. Trends of correlations between serum levels of growth hormone and insulin-like growth factor-I in general practice. Frontiers in endocrinology. vol 15. 2024-04-10. PMID:38596224. |
in contrast to the positive correlations found between the levels of gh and igf-i in patients with acromegaly ( |
2024-04-10 |
2024-04-12 |
Not clear |
| Giuseppe Grande, Andrea Graziani, Luca DE Toni, Alberto Ferli. Proteomics for the identification of peripheral markers in pituitary disease. Minerva endocrinology. 2024-04-09. PMID:38591851. |
in this narrative mini-review, the role of proteomics is discussed with a particular focus on the few attempts of the application of proteomic platforms for the identification of new biomarkers in pituitary diseases, namely in acromegaly, gh deficiency and male secondary hypogonadism. |
2024-04-09 |
2024-04-11 |
Not clear |
| Maryam Thaer Saadi, Noor Ulhuda G Mohammed, Baydaa Ahmed Abed, Layla Othman Farhan, Isam Noori Salma. Validity of galactin-3 in acromegaly: comparison with traditional markers. Irish journal of medical science. 2024-03-23. PMID:38520613. |
acromegaly occurs due to overproduction of growth hormone (gh) and insulin-like growth factor-1 (igf-1). |
2024-03-23 |
2024-03-26 |
Not clear |
| Lucio Vilar, Luciana Ansaneli Naves, Manoel Ricardo Alves Martins, Antônio Ribeiro-Oliveir. "Micromegaly": Acromegaly with apparently normal GH, an entity on its own? Best practice & research. Clinical endocrinology & metabolism. 2024-03-22. PMID:38519400. |
"micromegaly": acromegaly with apparently normal gh, an entity on its own? |
2024-03-22 |
2024-03-25 |
Not clear |
| Lucio Vilar, Luciana Ansaneli Naves, Manoel Ricardo Alves Martins, Antônio Ribeiro-Oliveir. "Micromegaly": Acromegaly with apparently normal GH, an entity on its own? Best practice & research. Clinical endocrinology & metabolism. 2024-03-22. PMID:38519400. |
a small proportion of the patients with acromegaly present with apparently normal basal gh levels and suppressible gh levels despite increased igf-1 levels, a pattern called micromegaly by some authors. |
2024-03-22 |
2024-03-25 |
Not clear |
| Tomoyuki Hata, Yoshikatsu Uematsu, Ayumi Sugita, Hisashi Adachi, Sayaka Kato, Maki Hirate, Kei-Ichiro Ishikura, Ayaka Kaku, Hiroki Ohara, Naoki Kojima, Teisuke Takahashi, Tomofumi Kurokaw. A Potent Neutralizing Monoclonal Antibody to Human Growth Hormone Suppresses Insulin-Like Growth Factor-1 in female Rats. Endocrinology. 2024-03-19. PMID:38500360. |
acromegaly and gigantism are disorders caused by hypersecretion of growth hormone (gh), usually from pituitary adenomas. |
2024-03-19 |
2024-03-21 |
mouse |
| Ahmed Anass Guerboub, Jad Issouani, Kesly Jeny Joumas, Yassine Er Rahal. Acromegaly among a Moroccan population. The Pan African medical journal. vol 46. 2024-03-11. PMID:38465009. |
acromegaly is defined as an acquired dysmorphytic syndrome due to excessive secretion of growth hormone (gh) and consequently of insulin-like growth factor-1 (igf-1). |
2024-03-11 |
2024-03-14 |
Not clear |
| E O Mamedova, E G Przhiyalkovskaya, S A Buryakina, E V Bondarenko, A M Lapshina, M Yu Pikunov, Zh E Belaya, G A Melnichenk. [Ectopic acromegaly due to bronchial neuroendocrine tumors: the first description in Russia of three clinical cases]. Problemy endokrinologii. vol 70. issue 1. 2024-03-04. PMID:38433543. |
in the majority of cases the cause of acromegaly is a pituitary tumor producing gh. |
2024-03-04 |
2024-03-06 |
Not clear |
| E O Mamedova, E G Przhiyalkovskaya, S A Buryakina, E V Bondarenko, A M Lapshina, M Yu Pikunov, Zh E Belaya, G A Melnichenk. [Ectopic acromegaly due to bronchial neuroendocrine tumors: the first description in Russia of three clinical cases]. Problemy endokrinologii. vol 70. issue 1. 2024-03-04. PMID:38433543. |
ectopic acromegaly occurs in cases of tumors which produce growth hormone-releasing hormone (ghrh) or extrapituitary tumors which produce gh. |
2024-03-04 |
2024-03-06 |
Not clear |
| Angelo Milioto, Giuliana Corica, Federica Nista, Luiz Eduardo Armondi Wildemberg, Federica Rossi, Bianca Bignotti, Mônica R Gadelha, Diego Ferone, Alberto Stefano Tagliafico, Federico Gatt. Skeletal Muscle Evaluation in Patients With Acromegaly. Journal of the Endocrine Society. vol 8. issue 4. 2024-03-04. PMID:38434516. |
patients with acromegaly are characterized by chronic exposure to high growth hormone (gh) and insulin-like growth factor-1 levels, known for their anabolic effect on skeletal muscle. |
2024-03-04 |
2024-03-06 |
Not clear |
| Patricia Fainstein-Day, Tamara Estefanía Ullmann, Mercedes Corina Liliana Dalurzo, Gustavo Emilio Sevlever, David Eduardo Smit. The clinical and biochemical spectrum of ectopic acromegaly. Best practice & research. Clinical endocrinology & metabolism. 2024-02-27. PMID:38413286. |
ectopic acromegaly is a rare condition caused by extrapituitary central or peripheral neuroendocrine tumours (net) that hypersecrete gh or, more commonly, ghrh. |
2024-02-27 |
2024-03-01 |
Not clear |
| Anna Bogusławska, Magdalena Godlewska, Alicja Hubalewska-Dydejczyk, Márta Korbonits, Jerzy Starzyk, Aleksandra Gilis-Januszewsk. Tall stature and gigantism in adult patients with acromegaly. European journal of endocrinology. 2024-02-23. PMID:38391173. |
increased height in patients with acromegaly could be a manifestation of growth hormone (gh) excess before epiphysis closure. |
2024-02-23 |
2024-02-25 |
Not clear |
| Anna Bogusławska, Magdalena Godlewska, Alicja Hubalewska-Dydejczyk, Márta Korbonits, Jerzy Starzyk, Aleksandra Gilis-Januszewsk. Tall stature and gigantism in adult patients with acromegaly. European journal of endocrinology. 2024-02-23. PMID:38391173. |
the aim of this study was to evaluate the relationship between the height of adult patients with gh excess related to mid-parental height (mph) and population mean and to find whether taller patients with acromegaly come from tall families. |
2024-02-23 |
2024-02-25 |
Not clear |
| Vittoria Favero, Benedetta Zampetti, Emanuela I Carioni, Paolo Dalino Ciaramella, Erika Grossrubatscher, Daniela Dallabonzana, Iacopo Chiodini, Renato Cozz. Efficacy of pasireotide LAR for acromegaly: a prolonged real-world monocentric study. Frontiers in endocrinology. vol 15. 2024-02-16. PMID:38362280. |
acromegaly is caused by excessive growth hormone (gh) and insulin-like growth factor 1 (igf1). |
2024-02-16 |
2024-02-18 |
Not clear |
| Fanny Chasseloup, Daniela Regazzo, Lucie Tosca, Alexis Proust, Emmanuelle Kuhn, Mirella Hage, Christel Jublanc, Karima Mokhtari, Mattia Dalle Nogare, Serena Avallone, Filippo Ceccato, Gerard Tachdjian, Sylvie Salenave, Jacques Young, Stephan Gaillard, Fabrice Parker, Anne-Laure Boch, Philippe Chanson, Jerome Bouligand, Gianluca Occhi, Peter Kamenick. KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas. European journal of endocrinology. 2024-02-08. PMID:38330165. |
paradoxical increase of gh following oral glucose load has been described in ∼30% of patients with acromegaly and has been related to the ectopic expression of the glucose-dependent insulinotropic polypeptide (gip) receptor (gipr) in somatotropinomas. |
2024-02-08 |
2024-02-11 |
Not clear |
| D Costa, C Pellicano, V Mercuri, E D'Ascanio, G Buglione, G Cicolani, U Basile, G Leodori, P Gargiulo, E Rosat. Role of IL33 in chronic inflammation and microvascular damage as a reflection of organ damage on a cohort of patients with acromegaly. Journal of endocrinological investigation. 2024-02-08. PMID:38329608. |
acromegaly is a rare chronic disease, caused by the over-secretion of growth hormone (gh), that creates a pro-inflammatory state, but the exact mechanisms by which gh or insulin-like growth factor 1 (igf-1) act on inflammatory cells are not fully understood. |
2024-02-08 |
2024-02-10 |
Not clear |